anonymous
Guest
anonymous
Guest
Who is in and who is out for senior leaders?
Who is in and who is out for senior leaders?
let’s only hope a majority of them. There is only evidence of behaviors like big pharma and we are not the size of company for that. We do not have the products for that either. All of the organizations were doing better growth wise before these big pharma leaders were brought on. Would be good for any of us left if there was a big exit and house cleaning. Eliminate at least half of those top two layers and there is even more savings.
The trolls web search comes up a day late and a dollar short once again with his/her late breaking news.Looks like Potter and Armin are out, and every leadership position is from Japan now.
https://www.sumitomo-pharma.com/news/assets/pdf/ene20240305.pdf
Whoever called a divestiture may be on point.
Sales reorg was already announced 2 months ago. The cuts now are in house cuts.Who is the next to go? Could we do a sales wide survey monkey?
Us Myovant peeps are not happy how they carved us up. Other divisions got off lightly.I can’t wait to get out of here!!!
Us Myovant peeps are not happy how they carved us up. Other divisions got off lightly.
Aw what like all 25 reps in neuro? Latuda was a massive laugh off you fool and yes Myovant will lose more people than Neuro.myovant peeps, a whole neurology division was eliminated and you make more than anyone here